首页 > 最新文献

Lviv clinical bulletin最新文献

英文 中文
Peculiarities of the Ukrainian model of Fracture Risk Assessment (FRAX®) among patients with liver cirrhosis accompanied by impaired bone mineral density: its diagnostic and prognostic value 乌克兰模型骨折风险评估(FRAX®)在肝硬化患者中伴有骨矿物质密度受损的特殊性:其诊断和预后价值
Pub Date : 2023-01-02 DOI: 10.25040/lkv2022.03-04.054
N. Drobinska, O. Abrahamovych, M. Abrahamovych, S. Tolopko, S. Guta, R. Ivanochko
Introduction. The problem of osteoporotic fractures and the evaluation thresholds for intervention in patients with liver cirrhosis (LC) remains obscure so far. Ukrainian model of fracture risk assessment (FRAX®) has never been implemented among patients with LC in Ukraine. The aim of the study. To find out the peculiarities of the Ukrainian model of Fracture Risk Assessment, its diagnostic and prognostic value for implementation among patients with liver cirrhosis accompanied by impaired bone mineral density. Materials and methods. 90 patients with LC (27 women and 63 men aged 18 to 66 years) were randomly assigned into the study. Stratification into groups was based on information about bone condition. 72 patients were included into an experimental group (EG, patients with impaired bone mineral density (IBMD), which was divided into two subgroups – EG A (patients with osteopenia, 46) and EG B (patients with osteoporosis, 26). Control group (CG) included 18 patients without IBMD. The peculiarities of the fracture risk factors and evaluation thresholds according to the Ukrainian FRAX® model (2019) amoung patients with LC with bone disorders were established (significant differences between frequency of features in groups and substantial stochastic associations of features with IBMD or its manifestations were investigated). The diagnostic characteristcs (diagnostic value, predictive value, likelihood ratio) of the detected features for IBMD in general, osteopenia and osteoporosis in particular, were revealed, and after that the post-test probability of certain bone disorders was determined among all patients with LC in the case of applying the identified features. The results. It was found that although most of the risk factors occurred more often in patients with bone disorders, significant differences were detected only between the frequency of previous fractures in EG and CG, including EG B and CG, and EG A and EG B; between the frequency of cases of normal body weight, as well as overweight in EG and CG, including EG B and CG. The evaluation thresholds according to the Ukrainian FRAX® model also differed significantly: the values above the upper evaluation threshold – in EG B and CG and in EG A and EG B; the intermediate values of fracture risk – in EG A and CG; the values below the lower evaluation threshold – in EG and CG, as well as in EG A and CG and in EG B and CG, including. Bone disorders had a substantial direct stochastic association in the following cases: IBMD in general – with the previous fractures, normal body weight and values above the upper evaluation threshold; osteopenia – with the previous fractures, normal body weight and intermediate values of fracture risk; osteoporosis – with the previous fractures, normal body weight and values above the upper evaluation threshold. All manifestations of bone disorders had substantial negative stochastic association with overweight and values below the lower evaluation threshold, as wel
介绍。肝硬化(LC)患者骨质疏松性骨折的问题及干预的评估阈值至今仍不明确。乌克兰骨折风险评估模型(FRAX®)从未在乌克兰LC患者中实施。研究的目的。探讨乌克兰骨折风险评估模型的特点及其在肝硬化伴骨密度受损患者中的诊断和预后价值。材料和方法。90例LC患者(27例女性,63例男性,年龄18 - 66岁)被随机分配到研究中。分组是基于骨骼状况的信息。将72例患者纳入实验组(EG,骨矿物质密度受损患者(IBMD)),实验组分为2个亚组,EG A(骨质减少患者,46例)和EG B(骨质疏松患者,26例)。对照组(CG) 18例无IBMD。根据乌克兰FRAX®模型(2019),确定LC合并骨疾病患者骨折危险因素和评估阈值的特殊性(研究各组特征频率之间的显著差异以及特征与IBMD或其表现之间的大量随机关联)。揭示一般IBMD,特别是骨质减少和骨质疏松症的检测特征的诊断特征(诊断价值、预测值、似然比),然后确定在应用识别特征的情况下,所有LC患者中某些骨骼疾病的检测后概率。结果。结果发现,虽然大多数危险因素在骨骼疾病患者中发生的频率更高,但只有EG和CG(包括EG B和CG,以及EG A和EG B)的既往骨折频率存在显著差异;正常体重的病例发生频率之间,以及超重的EG和CG,包括EG B和CG。根据乌克兰FRAX®模型的评价阈值也有显著差异:高于评价阈值的值-在EG B和CG以及EG A和EG B中;EG A和CG为骨折风险的中间值;在EG和CG、EG A和CG以及EG B和CG中低于较低评价阈值的值,包括。骨病在以下情况下有实质性的直接随机关联:一般的IBMD -与先前的骨折,正常体重和高于最高评估阈值的值;骨质减少-既往骨折,体重正常,骨折风险中等值;骨质疏松症-既往骨折,体重正常,且值高于评估上限。所有骨骼疾病的表现都与超重和低于下评价阈值的值以及矮身高骨质疏松症有显著的负随机关联(表明这些特征是正常骨密度所固有的)。研究发现,根据乌克兰FRAX®模型,骨折危险因素和评估阈值主要是单向量标记,因为它们可以确认被检测到的疾病,或者在没有它们的情况下否认它。先前的骨折对IBMD,特别是骨质疏松症具有高度特异性,可用于确认LC患者是否存在这些疾病。正常体重对IBMD和骨质疏松症具有中等特异性,但如果IBMD存在,则可以更有用地指示IBMD,并排除骨质疏松症。根据乌克兰FRAX®模型,高于最高评价阈值的值对骨质疏松症具有高度特异性,可以确认骨质疏松症的存在。根据乌克兰FRAX®模型,骨折风险的中间值对于骨质减少是中等特异性的,但如果不存在骨质减少,则可以更有用地排除骨质减少。超重,特别是低于较低评价阈值的值,很可能表明骨密度正常。结论。使用乌克兰骨折风险评估模型(FRAX®)具有一定的特殊性,可以作为检测或排除肝硬化患者骨矿物质密度受损的有价值的工具。
{"title":"Peculiarities of the Ukrainian model of Fracture Risk Assessment (FRAX®) among patients with liver cirrhosis accompanied by impaired bone mineral density: its diagnostic and prognostic value","authors":"N. Drobinska, O. Abrahamovych, M. Abrahamovych, S. Tolopko, S. Guta, R. Ivanochko","doi":"10.25040/lkv2022.03-04.054","DOIUrl":"https://doi.org/10.25040/lkv2022.03-04.054","url":null,"abstract":"Introduction. The problem of osteoporotic fractures and the evaluation thresholds for intervention in patients with liver cirrhosis (LC) remains obscure so far. Ukrainian model of fracture risk assessment (FRAX®) has never been implemented among patients with LC in Ukraine. The aim of the study. To find out the peculiarities of the Ukrainian model of Fracture Risk Assessment, its diagnostic and prognostic value for implementation among patients with liver cirrhosis accompanied by impaired bone mineral density. Materials and methods. 90 patients with LC (27 women and 63 men aged 18 to 66 years) were randomly assigned into the study. Stratification into groups was based on information about bone condition. 72 patients were included into an experimental group (EG, patients with impaired bone mineral density (IBMD), which was divided into two subgroups – EG A (patients with osteopenia, 46) and EG B (patients with osteoporosis, 26). Control group (CG) included 18 patients without IBMD. The peculiarities of the fracture risk factors and evaluation thresholds according to the Ukrainian FRAX® model (2019) amoung patients with LC with bone disorders were established (significant differences between frequency of features in groups and substantial stochastic associations of features with IBMD or its manifestations were investigated). The diagnostic characteristcs (diagnostic value, predictive value, likelihood ratio) of the detected features for IBMD in general, osteopenia and osteoporosis in particular, were revealed, and after that the post-test probability of certain bone disorders was determined among all patients with LC in the case of applying the identified features. The results. It was found that although most of the risk factors occurred more often in patients with bone disorders, significant differences were detected only between the frequency of previous fractures in EG and CG, including EG B and CG, and EG A and EG B; between the frequency of cases of normal body weight, as well as overweight in EG and CG, including EG B and CG. The evaluation thresholds according to the Ukrainian FRAX® model also differed significantly: the values above the upper evaluation threshold – in EG B and CG and in EG A and EG B; the intermediate values of fracture risk – in EG A and CG; the values below the lower evaluation threshold – in EG and CG, as well as in EG A and CG and in EG B and CG, including. Bone disorders had a substantial direct stochastic association in the following cases: IBMD in general – with the previous fractures, normal body weight and values above the upper evaluation threshold; osteopenia – with the previous fractures, normal body weight and intermediate values of fracture risk; osteoporosis – with the previous fractures, normal body weight and values above the upper evaluation threshold. All manifestations of bone disorders had substantial negative stochastic association with overweight and values below the lower evaluation threshold, as wel","PeriodicalId":279640,"journal":{"name":"Lviv clinical bulletin","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127722497","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Role Of HTRA Serine Peptidase 1, Vascular Endothelial Growth Factor А, Tumor Necrosis Factor Gene Polymorphisms in the Treatment Of Wet Age-Related Macular Degeneration HTRA丝氨酸肽酶1、血管内皮生长因子А、肿瘤坏死因子基因多态性在湿性年龄相关性黄斑变性治疗中的作用
Pub Date : 2023-01-02 DOI: 10.25040/lkv2022.03-04.045
N. Malachkova, O. Al-Jarrah
Introduction. Age-related macular degeneration (AMD) of the retina is still considered the leading cause of vision loss in the elderly. The multifactoriality of the disease impairs the clinical effectiveness of modern AMD treatment methods. however, the study of single-nucleotide polymorphisms, in particular, of the HtrA serine peptidase 1 (HTRA1), vascular endothelial growth factor A (VEGF A) and tumor necrosis factor (TNF) genesis a promising link on the way to improve and develope more effective treatment strategies of the disease. The Aim of the Study. To investigate role of HTRA 1, VEGF A and TNF gene polymorphisms in the treatment of wet age-related macular degeneration. Materials and Methods. 162 people with diagnosed wet AMD took part in the investigation. They received anti-VEGF A therapy in the form of injections of aflibercept monthly for half a year. Structural changes of the eyes were studied using optical coherence tomography (OCT); polymerase chain reaction (PCR) studies were performed using a Bio-Rad CFX 96 apparatus (BioRad, USA) using a reagent package (Lytech, Russia). Statistical analysis of the obtained results was performed using a set of software packages Statistica 10 (StatSoft, Inc., USA) and SPSS 23.0. Results. It was revealed best prognostic significance in patients with the TC rs2010963 genotype of the VEGFA gene was registered during the analysis of OCT 2 (RR=2.7; 95% CI 1.556 – 4.8), OCT 4 (RR=2.9 ; 95% CI 1.7 – 5.03) and OCT 8 (RR=2.6; 95% CI 1.6 – 4.12) sections, while in patients with the CC genotype these indicators in the OCT 2 section were: RR= 6.1; 95% CI 3.66 – 10.27; in OCT zone 4 RR=4.9; 95% CI 2.9 – 8.29, and in the OCT section 8: RR=4.23; 95% CI 2.7 – 6.556, which indicates a more pronounced influence of the CC genotype. When analyzing rs1800629 of the TNF gene, the best prognostic significance of the GA genotype was established in the OCT 4 (RR=1.77; 95% CI 1.218 – 2.56) and OCT 8 (RR=1.9; 95% CI 1.17 – 3.175) areas (p-value less than 0.05), with the AA genotype in OCT 4 (RR=3.77; 95% CI 2.17 – 6.58), OCT 8 (RR=3.1; 95% CI 1 .7 – 5.59) zones and when evaluating changes in visual acuity of patients with wet AMD (RR=4.2; 95% CI 2 – 8.98). No statistically significant results were found in the evaluation of the HTRA1 gene rs11200638 (p-value more than 0.05). Conclusions. The data obtained in our study indicate a direct influence of the vascular endothelial growth factor A (rs2010963) and tumor necrosis factor (rs1800629) polymorphisms on the emergence of resistance to aflibercept. However, the study of this influence in the presence of the HtrA serine peptidase 1 gene rs11200638 requires further research.
介绍。老年性视网膜黄斑变性(AMD)仍被认为是老年人视力丧失的主要原因。该疾病的多因素性影响了现代AMD治疗方法的临床有效性。然而,研究单核苷酸多态性,特别是HtrA丝氨酸肽酶1 (HTRA1)、血管内皮生长因子A (VEGF A)和肿瘤坏死因子(TNF)的发生,是改善和制定更有效的治疗策略的一个有希望的环节。研究的目的。探讨HTRA 1、VEGF A和TNF基因多态性在湿性年龄相关性黄斑变性治疗中的作用。材料与方法:162例湿性AMD患者参与调查。他们接受了抗vegf A治疗,每月注射阿伯西普,持续半年。使用光学相干断层扫描(OCT)研究眼睛的结构变化;聚合酶链反应(PCR)研究使用Bio-Rad CFX 96装置(BioRad,美国)和试剂包(Lytech,俄罗斯)进行。使用Statistica 10 (StatSoft, Inc., USA)和SPSS 23.0软件包对所得结果进行统计分析。结果。在OCT 2分析中发现,VEGFA基因的TC rs2010963基因型患者的预后具有最佳意义(RR=2.7;95% ci 1.556 - 4.8), 10月4日(rr =2.9;95% CI 1.7 - 5.03)和OCT 8 (RR=2.6;95% CI 1.6 - 4.12)切片,而CC基因型患者OCT 2切片的这些指标为:RR= 6.1;95% ci 3.66 - 10.27;OCT 4区RR=4.9;95% CI 2.9 - 8.29,在OCT切片8:RR=4.23;95% CI 2.7 - 6.556,表明CC基因型的影响更为显著。在分析TNF基因rs1800629时,GA基因型在OCT 4中具有最佳的预后意义(RR=1.77;95% CI 1.218 - 2.56)和OCT 8 (RR=1.9;95% CI 1.17 ~ 3.175)区(p值< 0.05),OCT 4为AA基因型(RR=3.77;95% ci 2.17 - 6.58), 10月8日(rr =3.1;95% CI为1.7 - 5.59),当评估湿性AMD患者的视力变化时(RR=4.2;95% ci 2 - 8.98)。HTRA1基因rs11200638的评价结果无统计学意义(p值大于0.05)。结论。我们的研究数据表明血管内皮生长因子a (rs2010963)和肿瘤坏死因子(rs1800629)多态性对阿布利塞普耐药的出现有直接影响。然而,在HtrA丝氨酸肽酶1基因rs11200638存在的情况下,这种影响的研究需要进一步的研究。
{"title":"The Role Of HTRA Serine Peptidase 1, Vascular Endothelial Growth Factor А, Tumor Necrosis Factor Gene Polymorphisms in the Treatment Of Wet Age-Related Macular Degeneration","authors":"N. Malachkova, O. Al-Jarrah","doi":"10.25040/lkv2022.03-04.045","DOIUrl":"https://doi.org/10.25040/lkv2022.03-04.045","url":null,"abstract":"Introduction. Age-related macular degeneration (AMD) of the retina is still considered the leading cause of vision loss in the elderly. The multifactoriality of the disease impairs the clinical effectiveness of modern AMD treatment methods. however, the study of single-nucleotide polymorphisms, in particular, of the HtrA serine peptidase 1 (HTRA1), vascular endothelial growth factor A (VEGF A) and tumor necrosis factor (TNF) genesis a promising link on the way to improve and develope more effective treatment strategies of the disease. The Aim of the Study. To investigate role of HTRA 1, VEGF A and TNF gene polymorphisms in the treatment of wet age-related macular degeneration. Materials and Methods. 162 people with diagnosed wet AMD took part in the investigation. They received anti-VEGF A therapy in the form of injections of aflibercept monthly for half a year. Structural changes of the eyes were studied using optical coherence tomography (OCT); polymerase chain reaction (PCR) studies were performed using a Bio-Rad CFX 96 apparatus (BioRad, USA) using a reagent package (Lytech, Russia). Statistical analysis of the obtained results was performed using a set of software packages Statistica 10 (StatSoft, Inc., USA) and SPSS 23.0. Results. It was revealed best prognostic significance in patients with the TC rs2010963 genotype of the VEGFA gene was registered during the analysis of OCT 2 (RR=2.7; 95% CI 1.556 – 4.8), OCT 4 (RR=2.9 ; 95% CI 1.7 – 5.03) and OCT 8 (RR=2.6; 95% CI 1.6 – 4.12) sections, while in patients with the CC genotype these indicators in the OCT 2 section were: RR= 6.1; 95% CI 3.66 – 10.27; in OCT zone 4 RR=4.9; 95% CI 2.9 – 8.29, and in the OCT section 8: RR=4.23; 95% CI 2.7 – 6.556, which indicates a more pronounced influence of the CC genotype. When analyzing rs1800629 of the TNF gene, the best prognostic significance of the GA genotype was established in the OCT 4 (RR=1.77; 95% CI 1.218 – 2.56) and OCT 8 (RR=1.9; 95% CI 1.17 – 3.175) areas (p-value less than 0.05), with the AA genotype in OCT 4 (RR=3.77; 95% CI 2.17 – 6.58), OCT 8 (RR=3.1; 95% CI 1 .7 – 5.59) zones and when evaluating changes in visual acuity of patients with wet AMD (RR=4.2; 95% CI 2 – 8.98). No statistically significant results were found in the evaluation of the HTRA1 gene rs11200638 (p-value more than 0.05). Conclusions. The data obtained in our study indicate a direct influence of the vascular endothelial growth factor A (rs2010963) and tumor necrosis factor (rs1800629) polymorphisms on the emergence of resistance to aflibercept. However, the study of this influence in the presence of the HtrA serine peptidase 1 gene rs11200638 requires further research.","PeriodicalId":279640,"journal":{"name":"Lviv clinical bulletin","volume":"181 1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121125822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Retrospective Analysis of the Spectrum of Congenital Malformations Diagnosed Prenatally Based on the Lviv Medical Genetics Center during 2018-2020 yy 基于利沃夫医学遗传中心2018-2020年产前诊断先天性畸形谱的回顾性分析
Pub Date : 2023-01-02 DOI: 10.25040/lkv2022.03-04.014
O. Hnateiko, N. Kitsera, N. Helner, M. Teneta, Z. Hnateiko, I. Vijtovych
Introduction. According to the WHO, about 3 % of infants worldwide are born with a congenital malformation (CM). The aim of the study. To conduct a retrospective analysis of the spectrum of congenital malformations diagnosed during pregnancy based on the Lviv Medical Genetics Center during 2018-2020 yy. Materials and methods. Clinical and epidemiological, as well as medical and statistical data on CM diagnosed prenatally between 2018-2020 were collected from primary source documents (Form No. 49) and then analyzed at the Lviv Medical Genetics Center ʺInstitute of Hereditary Pathology, National Academy of Medical Sciences of Ukraineʺ, Lviv. The Student’s t-test was used to determine the difference between the arithmetic means. The null hypotheses were tested using a t-test at the significance level of p-value less than 0.05. Results. A total of 11062 pregnant women were examined between 2018-2020: CM at different stages of pregnancy were diagnosed in 454 cases, which accounted for 4.1 % of cases and did not exceed the population value. There was a 2.3-fold reduction in the number of pregnant women presented to the Medical Genetics Center in 2020, probably due to the global coronavirus pandemic – from 5007 women in 2018 to 2212 females in 2020. However, the number of CM diagnosed prenatally in 2020 was not statistically significant (p-value more than 0.05) as compared to the average value for these years and 2018. In 2018, a total of 5007 pregnant women were examined at the Lviv Medical Genetics Center. In 136 (4.8 %) cases, fetal malformations were diagnosed before 22 weeks of gestation, while in 26 (1.2 %) cases, pregnancy was affected by congenital anomaly in its second half. In 2019, there were examined 3843 pregnant women. In169 (7.8 %) cases, CM were diagnosed before 22 weeks of gestation, that was statistically significant as compared to 2018 (p-value less than 0.05) and in 20 (1.2 %) cases, fetal anomalies were detected in the second half of pregnancy, that was not statistically significant as compared to the previous year (p-value more than 0.05). In 2020, we examined 2212 pregnant women. Reducing the number of visits to our medical center was probably due to the coronavirus pandemic. There were95 (5.0 %) cases of fetal malformations diagnosed before 22 weeks of gestation and 8 (2.5 %) cases of congenital anomalies detected in the second half of pregnancy. The number of CM diagnosed prenatally was the highest in 2019 – 4.9 %; however, there was no statistically significant difference (p-value more than 0.05) in the average values for these years – 4.1 % and 3.2 % in 2020 and 2018, respectively. In 2020, the incidence of congenital malformations diagnosed after 22 weeks of gestation was significantly higher (p-value less than 0.05) than in other years – 2.5 % and 1.2 %, respectively. Conclusions. Between 2018-2020, the incidence of congenital malformations diagnosed at different stages of pregnancy was 4.1 %. Congenital malformation s of th
介绍。根据世界卫生组织的数据,全世界约有3%的婴儿出生时患有先天性畸形(CM)。研究的目的。回顾性分析2018-2020年期间在利沃夫医学遗传中心诊断的妊娠期先天性畸形谱。材料和方法。收集2018-2020年间产前诊断CM的临床和流行病学以及医学和统计数据(表格49号),然后在利沃夫医学遗传中心/乌克兰国家医学科学院/遗传病理研究所/利沃夫进行分析。学生t检验用于确定算术平均值之间的差异。在p值小于0.05的显著性水平上,使用t检验对原假设进行检验。结果。2018-2020年共对11062名孕妇进行检查,诊断为不同妊娠阶段CM的454例,占4.1%,未超过人群值。可能是由于全球冠状病毒大流行,2020年向医学遗传学中心提交的孕妇人数减少了2.3倍,从2018年的5007名女性减少到2020年的2212名女性。然而,2020年产前诊断CM的数量与这些年和2018年的平均值相比,无统计学意义(p值大于0.05)。2018年,共有5007名孕妇在利沃夫医学遗传中心接受了检查。在136例(4.8%)病例中,胎儿畸形在妊娠22周之前被诊断出来,而在26例(1.2%)病例中,妊娠后半期受到先天性异常的影响。2019年,共有3843名孕妇接受了检查。妊娠22周前诊断CM的有169例(7.8%),与2018年比较有统计学意义(p值< 0.05);妊娠后半期发现胎儿异常的有20例(1.2%),与上一年比较无统计学意义(p值> 0.05)。2020年,我们对2212名孕妇进行了检查。减少我们医疗中心的就诊次数可能是由于冠状病毒大流行。在妊娠22周前诊断出胎儿畸形95例(5.0%),在妊娠后半期发现先天性异常8例(2.5%)。2019年产前诊断的CM数量最高,为4.9%;然而,这些年的平均值没有统计学上的显著差异(p值大于0.05)——2020年和2018年分别为4.1%和3.2%。2020年,妊娠22周后诊断的先天性畸形发生率显著高于其他年份(p值小于0.05),分别为2.5%和1.2%。结论。2018-2020年间,在妊娠不同阶段诊断出的先天性畸形发生率为4.1%。妊娠22周前以神经系统先天性畸形(Q00-Q07)最为常见,妊娠22周后以泌尿系统先天性畸形(Q60-Q64)最为常见。产前医学的主要任务是及时诊断可纠正的发育缺陷,以及产科医生、新生儿科医生、小儿神经科医生、儿科医生和其他卫生保健专业人员的共同努力,确保正常分娩,为婴儿提供专业护理,随后是终身康复。
{"title":"A Retrospective Analysis of the Spectrum of Congenital Malformations Diagnosed Prenatally Based on the Lviv Medical Genetics Center during 2018-2020 yy","authors":"O. Hnateiko, N. Kitsera, N. Helner, M. Teneta, Z. Hnateiko, I. Vijtovych","doi":"10.25040/lkv2022.03-04.014","DOIUrl":"https://doi.org/10.25040/lkv2022.03-04.014","url":null,"abstract":"Introduction. According to the WHO, about 3 % of infants worldwide are born with a congenital malformation (CM). The aim of the study. To conduct a retrospective analysis of the spectrum of congenital malformations diagnosed during pregnancy based on the Lviv Medical Genetics Center during 2018-2020 yy. Materials and methods. Clinical and epidemiological, as well as medical and statistical data on CM diagnosed prenatally between 2018-2020 were collected from primary source documents (Form No. 49) and then analyzed at the Lviv Medical Genetics Center ʺInstitute of Hereditary Pathology, National Academy of Medical Sciences of Ukraineʺ, Lviv. The Student’s t-test was used to determine the difference between the arithmetic means. The null hypotheses were tested using a t-test at the significance level of p-value less than 0.05. Results. A total of 11062 pregnant women were examined between 2018-2020: CM at different stages of pregnancy were diagnosed in 454 cases, which accounted for 4.1 % of cases and did not exceed the population value. There was a 2.3-fold reduction in the number of pregnant women presented to the Medical Genetics Center in 2020, probably due to the global coronavirus pandemic – from 5007 women in 2018 to 2212 females in 2020. However, the number of CM diagnosed prenatally in 2020 was not statistically significant (p-value more than 0.05) as compared to the average value for these years and 2018. In 2018, a total of 5007 pregnant women were examined at the Lviv Medical Genetics Center. In 136 (4.8 %) cases, fetal malformations were diagnosed before 22 weeks of gestation, while in 26 (1.2 %) cases, pregnancy was affected by congenital anomaly in its second half. In 2019, there were examined 3843 pregnant women. In169 (7.8 %) cases, CM were diagnosed before 22 weeks of gestation, that was statistically significant as compared to 2018 (p-value less than 0.05) and in 20 (1.2 %) cases, fetal anomalies were detected in the second half of pregnancy, that was not statistically significant as compared to the previous year (p-value more than 0.05). In 2020, we examined 2212 pregnant women. Reducing the number of visits to our medical center was probably due to the coronavirus pandemic. There were95 (5.0 %) cases of fetal malformations diagnosed before 22 weeks of gestation and 8 (2.5 %) cases of congenital anomalies detected in the second half of pregnancy. The number of CM diagnosed prenatally was the highest in 2019 – 4.9 %; however, there was no statistically significant difference (p-value more than 0.05) in the average values for these years – 4.1 % and 3.2 % in 2020 and 2018, respectively. In 2020, the incidence of congenital malformations diagnosed after 22 weeks of gestation was significantly higher (p-value less than 0.05) than in other years – 2.5 % and 1.2 %, respectively. Conclusions. Between 2018-2020, the incidence of congenital malformations diagnosed at different stages of pregnancy was 4.1 %. Congenital malformation s of th","PeriodicalId":279640,"journal":{"name":"Lviv clinical bulletin","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117038094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Colonization of new and reused dental implant healing abutments by oral microbiota during implantation period 种植期间口腔微生物群对新牙种植体和再生牙种植体愈合基台的定植
Pub Date : 2023-01-02 DOI: 10.25040/lkv2022.03-04.040
V. Vovk, M. Panaś, M. Sobchyshyn, P. Kriukov
Introduction. Reuse of implant healing abutments is common in dental practice, mainly due to economical reasons. The aim of the study. To analyze and compare the colonization of new and reused dental implant healing abutments by oral microbiota in patients subjected to dental implantation. Materials and methods. 4 groups, 20 patients, 36 healing abutments were examined using clinical and microbiological methods. Results. Clinical and microbiological analysis showed that biofilm formation was statistically higher on the reused IHAs compared to the new ones. Conclusions. The practice of administration of the reused healing abutments between patients should be reconsidered.
介绍。由于经济原因,种植体修复基台的重复使用在牙科实践中很常见。研究的目的。目的:分析和比较种植患者口腔微生物群对新种植体和重复使用种植体愈合基台的定植情况。材料和方法。采用临床及微生物学方法对4组20例患者、36个愈合基牙进行检查。结果。临床和微生物学分析表明,重复使用的IHAs与新IHAs相比,生物膜的形成在统计学上更高。结论。应重新考虑患者之间使用修复基台的做法。
{"title":"Colonization of new and reused dental implant healing abutments by oral microbiota during implantation period","authors":"V. Vovk, M. Panaś, M. Sobchyshyn, P. Kriukov","doi":"10.25040/lkv2022.03-04.040","DOIUrl":"https://doi.org/10.25040/lkv2022.03-04.040","url":null,"abstract":"Introduction. Reuse of implant healing abutments is common in dental practice, mainly due to economical reasons. The aim of the study. To analyze and compare the colonization of new and reused dental implant healing abutments by oral microbiota in patients subjected to dental implantation. Materials and methods. 4 groups, 20 patients, 36 healing abutments were examined using clinical and microbiological methods. Results. Clinical and microbiological analysis showed that biofilm formation was statistically higher on the reused IHAs compared to the new ones. Conclusions. The practice of administration of the reused healing abutments between patients should be reconsidered.","PeriodicalId":279640,"journal":{"name":"Lviv clinical bulletin","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130103218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Role of Intestinal Microbiota, Endotoxemia and Systemic Inflammation in the Pathogenesis of Nonalcoholic Fatty Liver Disease 肠道菌群、内毒素血症和全身性炎症在非酒精性脂肪肝发病中的作用
Pub Date : 2023-01-02 DOI: 10.25040/lkv2022.03-04.008
G. Fadieienko, А. Gridnev, I. Kushnir, T. Solomentseva, V. Chernova, V. Galchіnskaya
Introduction. Currently there are few and contradictory data concerning the influence of intestinal microbiota (IM) disturbances on the nature and severity of inflammatory processes in the liver tissue, the role of microbial metabolites in the activation of steatosis and fibrosis processes in patients with non-alcoholic fatty liver disease (NAFLD). The aim of the study. To clarify the role of intestinal microbiota, endotoxemia and systemic inflammation in the development and progression of nonalcoholic fatty liver disease. Materials and methods. 108 patients with NAFLD were examined, control group included 30 people. Detection of CRP and TNF-alpha levels, endotoxin in blood serum was carried out by the immunoenzymatic method. Determination of IM composition at the level of the main phylotypes was carried out by the method of quantitative polymerase chain reaction in real time. Results. A weak direct correlation between TNF-alpha, CRP and endotoxin with Firmicutes content (F), and an inverse correlation between CRP with Bacteroidetes content (B) was revealed. The dependence of the ratio of main intestinal phyla (F/B) on markers of systemic inflammation in NAFLD patients with different levels of endotoxin was evaluated. In patients with NAFLD, as endotoxin concentration increased, a deeper imbalance of IM was observed. In the group of patients with NAFLD with a high level of endotoxin, the maximum values of the F/B index were observed. Also, the increase in the intestinal permeability of the mucous barrier depended not only on changes in the IM, but also on systemic inflammation. The highest levels of endotoxemia were observed in patients with a high F/B index and increased activity of pro-inflammatory markers. In patients with NAFLD with varying degrees of fatty infiltration of the liver, an imbalance of IM was detected in comparison with the control group. As the degree of steatosis increased in NAFLD patients, an increase in Firmicutes content was observed. The maximum shift in the balance of the main phyla towards a decrease in the relative content of Bacteroidetes and an increase in Firmicutes was determined in patients with 3rd degree of steatosis (p-value less than 0.05). In the group of patients with a low and moderate degree of steatosis, a similar trend of IM disorders was observed, but these changes were insignificant. The relative number of Actinobacteria exposed no differences between the examined patients. The analysis of changes in IM in patients with NAFLD depending on the stage of liver fibrosis revealed no significant differences both from the control group and between groups with different degrees of fibrosis. The obtained data indicate that the imbalance of IM makes a significant contribution to the development of liver steatosis, while other important factors are involved in the formation of fibrosis processes, in particular, inflammation, the activity of intestinal metabolites and regulatory molecules. Conclusions.The imbalanc
介绍。目前,关于肠道微生物群(IM)紊乱对肝组织炎症过程的性质和严重程度的影响,以及微生物代谢物在非酒精性脂肪性肝病(NAFLD)患者脂肪变性和纤维化过程激活中的作用,数据很少且相互矛盾。研究的目的。阐明肠道菌群、内毒素血症和全身性炎症在非酒精性脂肪性肝病发生和进展中的作用。材料和方法。对108例NAFLD患者进行检查,对照组30例。采用免疫酶法检测血清CRP、tnf - α、内毒素水平。采用实时定量聚合酶链反应法测定主要种型水平的IM组成。结果。tnf - α、CRP和内毒素与厚壁菌门含量(F)呈微弱的直接相关,而CRP与拟杆菌门含量(B)呈负相关。评价不同内毒素水平NAFLD患者主肠门比值(F/B)对全身性炎症标志物的依赖性。在NAFLD患者中,随着内毒素浓度的升高,IM的失衡程度加深。在内毒素水平较高的NAFLD组,观察F/B指数的最大值。此外,肠粘膜屏障通透性的增加不仅取决于IM的变化,还与全身炎症有关。在高F/B指数和促炎标志物活性增加的患者中观察到最高水平的内毒素血症。在不同程度的脂肪浸润肝脏的NAFLD患者中,与对照组相比,检测到IM失衡。随着NAFLD患者脂肪变性程度的增加,观察到厚壁菌门含量增加。在3度脂肪变性患者中,主要门的平衡向拟杆菌门相对含量下降和厚壁菌门相对含量增加的最大方向移动(p值小于0.05)。在低中度脂肪变性患者组中,观察到类似的IM障碍趋势,但这些变化不显著。放线菌暴露的相对数量在检查的患者之间没有差异。分析NAFLD患者IM随肝纤维化分期的变化,结果显示与对照组及不同纤维化程度组间无显著差异。所获得的数据表明,IM的失衡对肝脏脂肪变性的发展有重要贡献,而其他重要因素也参与了纤维化过程的形成,特别是炎症、肠道代谢物的活性和调节分子。结论。肠道菌群失衡导致厚壁菌门增加,导致肠道代谢物产生增加,随后引发全身性炎症,刺激肝细胞脂肪积累,影响脂肪变性的进展和肝脏纤维化过程。
{"title":"The Role of Intestinal Microbiota, Endotoxemia and Systemic Inflammation in the Pathogenesis of Nonalcoholic Fatty Liver Disease","authors":"G. Fadieienko, А. Gridnev, I. Kushnir, T. Solomentseva, V. Chernova, V. Galchіnskaya","doi":"10.25040/lkv2022.03-04.008","DOIUrl":"https://doi.org/10.25040/lkv2022.03-04.008","url":null,"abstract":"Introduction. Currently there are few and contradictory data concerning the influence of intestinal microbiota (IM) disturbances on the nature and severity of inflammatory processes in the liver tissue, the role of microbial metabolites in the activation of steatosis and fibrosis processes in patients with non-alcoholic fatty liver disease (NAFLD). The aim of the study. To clarify the role of intestinal microbiota, endotoxemia and systemic inflammation in the development and progression of nonalcoholic fatty liver disease. Materials and methods. 108 patients with NAFLD were examined, control group included 30 people. Detection of CRP and TNF-alpha levels, endotoxin in blood serum was carried out by the immunoenzymatic method. Determination of IM composition at the level of the main phylotypes was carried out by the method of quantitative polymerase chain reaction in real time. Results. A weak direct correlation between TNF-alpha, CRP and endotoxin with Firmicutes content (F), and an inverse correlation between CRP with Bacteroidetes content (B) was revealed. The dependence of the ratio of main intestinal phyla (F/B) on markers of systemic inflammation in NAFLD patients with different levels of endotoxin was evaluated. In patients with NAFLD, as endotoxin concentration increased, a deeper imbalance of IM was observed. In the group of patients with NAFLD with a high level of endotoxin, the maximum values of the F/B index were observed. Also, the increase in the intestinal permeability of the mucous barrier depended not only on changes in the IM, but also on systemic inflammation. The highest levels of endotoxemia were observed in patients with a high F/B index and increased activity of pro-inflammatory markers. In patients with NAFLD with varying degrees of fatty infiltration of the liver, an imbalance of IM was detected in comparison with the control group. As the degree of steatosis increased in NAFLD patients, an increase in Firmicutes content was observed. The maximum shift in the balance of the main phyla towards a decrease in the relative content of Bacteroidetes and an increase in Firmicutes was determined in patients with 3rd degree of steatosis (p-value less than 0.05). In the group of patients with a low and moderate degree of steatosis, a similar trend of IM disorders was observed, but these changes were insignificant. The relative number of Actinobacteria exposed no differences between the examined patients. The analysis of changes in IM in patients with NAFLD depending on the stage of liver fibrosis revealed no significant differences both from the control group and between groups with different degrees of fibrosis. The obtained data indicate that the imbalance of IM makes a significant contribution to the development of liver steatosis, while other important factors are involved in the formation of fibrosis processes, in particular, inflammation, the activity of intestinal metabolites and regulatory molecules. Conclusions.The imbalanc","PeriodicalId":279640,"journal":{"name":"Lviv clinical bulletin","volume":"119 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133345498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Calcium-phosphorus metabolism and markers of its regulation in patients with rheumatoid arthritis with violation of bone mineral density: character and diagnostic value 类风湿性关节炎骨密度异常患者钙磷代谢及其调控标志物的特征及诊断价值
Pub Date : 2023-01-02 DOI: 10.25040/lkv2022.03-04.076
V. Chemes, O. Abrahamovych, U. Abrahamovych, R. Ivanochko, L. Kobak
Introduction. Patients with rheumatoid arthritis (RA) are twice as likely to have osteoporosis (OP) compared to the general population. The strength of bones depends on mineral substances, mainly represented by calcium phosphate microcrystals. The chief role in the regulation of calcium-phosphorus metabolism is played by vitamin D and parathormone (PTH). The aim of the study. To investigate markers of calcium-phosphorus metabolism in patients with rheumatoid arthritis accompanied by bone mineral density (BMD) disorders and to find out their diagnostic value. Materials and methods. 76 patients with RA (64 premenopausal women and 12 mature men) were included in the study. All patients with RA were subjected to ultrasound bone densitometry and according to its results, patients were divided into three groups: patients with RA and osteopenia, patients with RA and OP; RA patients without BMD disorders. The control group included 22 healthy individuals of both genders without BMD abnormalities. To evaluate calcium-phosphorus metabolism, ionized calcium, total calcium, phosphorus, PTH, and vitamin D in blood serum, and levels of calcium and phosphorus in urine were detected. Results. It was revealed that concentration of total calcium in blood serum of patients with RA is lower compared to healthy individuals, while the same index in urine of patients with RA accompanied by osteopenia, OP or without BMD disorders is higher compared to healthy people. The concentration of vitamin D is significantly lower in patients with RA and OP compared to patients with RA with osteopenia, without BMD disorders, or healthy individuals. The concentration of PTH is higher in healthy individuals compared to patients with RA without BMD abnormalities or with osteopenia. Conclusions. In patients with rheumatoid arthritis with osteopenia or osteoporosis, significantly more often than in patients with rheumatoid arthritis without a violation of bone mineral density, ionized and total calcium, phosphorus in serum and urine, as well as vitamin D indices have deviations from the reference values and are of diagnostic significance.
介绍。类风湿性关节炎(RA)患者患骨质疏松症(OP)的可能性是一般人群的两倍。骨骼的强度取决于矿物质,主要以磷酸钙微晶体为代表。维生素D和甲状旁腺激素(PTH)在钙磷代谢的调节中起主要作用。研究的目的。探讨类风湿性关节炎合并骨密度(BMD)紊乱患者钙磷代谢指标及其诊断价值。材料和方法。76例RA患者(64例绝经前女性和12例成熟男性)纳入研究。所有RA患者均行超声骨密度测定,根据超声骨密度测定结果将患者分为RA合并骨质减少组、RA合并OP组;无骨密度障碍的RA患者。对照组包括22名没有骨密度异常的男女健康个体。为评价钙磷代谢,检测血清中游离钙、总钙、磷、甲状旁腺素、维生素D及尿中钙磷水平。结果。结果表明,RA患者血清总钙浓度低于健康人,而伴有骨质减少、OP或无骨密度障碍的RA患者尿液总钙浓度高于健康人。RA和OP患者的维生素D浓度明显低于RA伴骨质减少、无骨密度障碍或健康个体。健康人的甲状旁腺激素浓度高于无骨密度异常或骨质减少的RA患者。结论。类风湿关节炎患者伴骨质减少或骨质疏松明显多于未违反骨密度的类风湿关节炎患者,血清和尿液中游离钙和总钙、磷以及维生素D指标均偏离参考值,具有诊断意义。
{"title":"Calcium-phosphorus metabolism and markers of its regulation in patients with rheumatoid arthritis with violation of bone mineral density: character and diagnostic value","authors":"V. Chemes, O. Abrahamovych, U. Abrahamovych, R. Ivanochko, L. Kobak","doi":"10.25040/lkv2022.03-04.076","DOIUrl":"https://doi.org/10.25040/lkv2022.03-04.076","url":null,"abstract":"Introduction. Patients with rheumatoid arthritis (RA) are twice as likely to have osteoporosis (OP) compared to the general population. The strength of bones depends on mineral substances, mainly represented by calcium phosphate microcrystals. The chief role in the regulation of calcium-phosphorus metabolism is played by vitamin D and parathormone (PTH). The aim of the study. To investigate markers of calcium-phosphorus metabolism in patients with rheumatoid arthritis accompanied by bone mineral density (BMD) disorders and to find out their diagnostic value. Materials and methods. 76 patients with RA (64 premenopausal women and 12 mature men) were included in the study. All patients with RA were subjected to ultrasound bone densitometry and according to its results, patients were divided into three groups: patients with RA and osteopenia, patients with RA and OP; RA patients without BMD disorders. The control group included 22 healthy individuals of both genders without BMD abnormalities. To evaluate calcium-phosphorus metabolism, ionized calcium, total calcium, phosphorus, PTH, and vitamin D in blood serum, and levels of calcium and phosphorus in urine were detected. Results. It was revealed that concentration of total calcium in blood serum of patients with RA is lower compared to healthy individuals, while the same index in urine of patients with RA accompanied by osteopenia, OP or without BMD disorders is higher compared to healthy people. The concentration of vitamin D is significantly lower in patients with RA and OP compared to patients with RA with osteopenia, without BMD disorders, or healthy individuals. The concentration of PTH is higher in healthy individuals compared to patients with RA without BMD abnormalities or with osteopenia. Conclusions. In patients with rheumatoid arthritis with osteopenia or osteoporosis, significantly more often than in patients with rheumatoid arthritis without a violation of bone mineral density, ionized and total calcium, phosphorus in serum and urine, as well as vitamin D indices have deviations from the reference values and are of diagnostic significance.","PeriodicalId":279640,"journal":{"name":"Lviv clinical bulletin","volume":"24 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116522379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
7th McMaster International Review Course in Internal Medicine (MIRCIM) – 29.09-01.10.2022 (Krakow, Republic of Poland) 第七届麦克马斯特国际内科回顾课程(MIRCIM) - 29.09-01.10.2022(波兰共和国克拉科夫)
Pub Date : 2023-01-02 DOI: 10.25040/lkv2022.03-04.087
T. Negrych, O. Fayura, V. Chemes, L. Tsyganyk, I. Korniychuk, M. Farmaha, A. Fedets
On September 28 – October 1, 2022, the 7th MIRCIM 2022 international conference was held in Krakow (Poland). The conference, which brought together internal medicine doctors, family doctors, narrow specialists of a therapeutic profile, had eight sections corresponding to eight main sections of internal medicine – cardiology, endocrinology, pulmonology, nephrology, rheumatology, gastroenterology, hematology, chronic infections. Professors with international recognition from the USA, Canada, Germany, France, Great Britain, Israel, India, and Mexico had the lectures. In the endocrinological section, the determination of the content of thyroid hormone, the diabetes mellitus treatment new possibilities, the experience of diagnosis and treatment of glucocorticosteroid-induced adrenal insufficiency were discussed. In the section of cardiovascular diseases, the speakers proposed to discuss the issue of acute heart failure, differences in the occurrence and course of cardiovascular diseases in women and men. In the pulmonology session, the lectures on the modern treatment of asthma, the use of nonsteroidal anti-inflammatory drugs in patients with respiratory diseases exacerbations, and the issue of the chronic obstructive pulmonary disease severity course reducing were presented. The nephrology section was presented by the reports on the topics: “Infections and kidneys”, “Optimal nephroprotection in patients with chronic kidney disease”. Professor Tracy Balboni emphasized the importance of spiritual care in the treatment of the critically ill patients and the role of spirituality in medicine and health care in general. The gastroenterology block of reports was devoted to the tactics of management and treatment of helicobacter pylori infection, intestinal polyps and non-alcoholic fatty liver disease. As part of the hematology unit, Professor Andreas Greinacher spoke about heparin-induced, vaccine-induced and other immune thrombocytopenias. At the rheumatology section.
2022年9月28日至10月1日,第七届MIRCIM 2022国际会议在波兰克拉科夫举行。这次会议汇集了内科医生、家庭医生、治疗方面的狭窄专家,会议分为八个部分,对应内科的八个主要部分——心脏病学、内分泌学、肺病学、肾脏病学、风湿病学、胃肠病学、血液学、慢性感染。来自美国、加拿大、德国、法国、英国、以色列、印度和墨西哥的国际知名教授主讲。内分泌科讨论了甲状腺激素含量的测定、糖尿病治疗的新可能性、糖皮质激素致肾上腺功能不全的诊治经验。在心血管疾病一节中,发言者提议讨论急性心力衰竭问题、男女心血管疾病发生和病程的差异。在肺内科部分,介绍了哮喘的现代治疗,呼吸系统疾病加重患者使用非甾体抗炎药,以及慢性阻塞性肺疾病严重程度降低的问题。肾内科部分的报告题目为:"感染与肾脏"、"慢性肾病患者的最佳肾保护"。特雷西·巴尔博尼教授强调了精神护理在治疗危重病人中的重要性,以及精神护理在医学和保健中的作用。报告的胃肠病学块致力于管理和治疗幽门螺杆菌感染,肠息肉和非酒精性脂肪肝的策略。作为血液学单元的一部分,Andreas Greinacher教授谈到了肝素诱导、疫苗诱导和其他免疫性血小板减少症。在风湿病科。
{"title":"7th McMaster International Review Course in Internal Medicine (MIRCIM) – 29.09-01.10.2022 (Krakow, Republic of Poland)","authors":"T. Negrych, O. Fayura, V. Chemes, L. Tsyganyk, I. Korniychuk, M. Farmaha, A. Fedets","doi":"10.25040/lkv2022.03-04.087","DOIUrl":"https://doi.org/10.25040/lkv2022.03-04.087","url":null,"abstract":"On September 28 – October 1, 2022, the 7th MIRCIM 2022 international conference was held in Krakow (Poland). The conference, which brought together internal medicine doctors, family doctors, narrow specialists of a therapeutic profile, had eight sections corresponding to eight main sections of internal medicine – cardiology, endocrinology, pulmonology, nephrology, rheumatology, gastroenterology, hematology, chronic infections. Professors with international recognition from the USA, Canada, Germany, France, Great Britain, Israel, India, and Mexico had the lectures. In the endocrinological section, the determination of the content of thyroid hormone, the diabetes mellitus treatment new possibilities, the experience of diagnosis and treatment of glucocorticosteroid-induced adrenal insufficiency were discussed. In the section of cardiovascular diseases, the speakers proposed to discuss the issue of acute heart failure, differences in the occurrence and course of cardiovascular diseases in women and men. In the pulmonology session, the lectures on the modern treatment of asthma, the use of nonsteroidal anti-inflammatory drugs in patients with respiratory diseases exacerbations, and the issue of the chronic obstructive pulmonary disease severity course reducing were presented. The nephrology section was presented by the reports on the topics: “Infections and kidneys”, “Optimal nephroprotection in patients with chronic kidney disease”. Professor Tracy Balboni emphasized the importance of spiritual care in the treatment of the critically ill patients and the role of spirituality in medicine and health care in general. The gastroenterology block of reports was devoted to the tactics of management and treatment of helicobacter pylori infection, intestinal polyps and non-alcoholic fatty liver disease. As part of the hematology unit, Professor Andreas Greinacher spoke about heparin-induced, vaccine-induced and other immune thrombocytopenias. At the rheumatology section.","PeriodicalId":279640,"journal":{"name":"Lviv clinical bulletin","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114606431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Circulatory System Organs Comorbid Lesions in Patients with Systemic Lupus Erythematosus: Nature and Frequency; Characteristics Depending on Gender, Age and Disease Duration 系统性红斑狼疮患者循环系统脏器合并症的性质及发生频率特征取决于性别、年龄和病程
Pub Date : 2023-01-02 DOI: 10.25040/lkv2022.03-04.066
L. Kobak, O. Abrahamovych, U. Abrahamovych, R. Ivanochko, V. Chemes
Introduction. Systemic lupus erythematosus (SLE) is a disease with numerous clinical manifestations and an unpredictable course. It often lasts for several months or years, with alternating remissions and exacerbations. Multiple organs can be affected simultaneously with varying degrees of severity, resulting in treatment- and disease-related comorbidities, including circulatory system diseases, which are one of the leading causes of death of SLE patients. The aim of the study. To find out the nature and frequency of the circulatory system organs comorbid lesions in patients with systemic lupus erythematosus, to characterize them depending on the gender, age and the disease duration. Materials and methods. Prior to performing the study all patients signed the voluntary consent to participate in accordance with the requirements of Helsinki Declaration of Human Rights, the Council of Europe Convention on Human Rights and Biomedicine. The cohort under investigation included 112 patients with diagnosed SLE of different severity with preliminary stratification as follows: females 89.29 %, patients of working age (57.14 % – young and 39.29 % – middle aged), unemployed (58.04 %), III disability group patients (45.54 %), city residents (62.50 %). According to the results of the disease duration assessment, a significant number of patients with SLE and circulatory system organs comorbid lesions have been ill for 1–5 years (36.61 %) and more than 10 years (38.39 %). All of them were patients of the rheumatology department of the Communal Non-Profit Enterprise of the Lviv Regional Council “Lviv Regional Clinical Hospital” from 2016 to 2021.The research was carried out in several stages, during which the nature and frequency of the circulatory system comorbid lesions with respect to gender, age and disease duration were estimated. Results. While completing the study, almost half of patients with SLE were diagnosed with Raynaud’s syndrome, mitral valve insufficiency and atherosclerosis, about 1/3 – with myocarditis, retinal angiopathy, symptomatic arterial hypertension and livedo reticularis. The varicose veins of the lower extremities, hypertensive disease, diffuse cardiosclerosis, tricuspid valve insufficiency, vein thrombosis, post-thrombophlebitis syndrome, aortic valve insufficiency, capillaritis, pulmonary hypertension, coronary artery disease (CAD) including stable angina pectoris, cardiomyopathy and post-infarction cardiosclerosis were found with the decreasing frequency. Raynaud’s syndrome was significantly more often diagnosed in females and young people; retinal angiopathy, livedo reticularis and symptomatic arterial hypertension – in females and those patients whose SLE lasted for more than 10 years; myocarditis, varicose veins of the lower extremities – in males; capillaritis – in patients with the shortest duration of SLE; atherosclerosis and mitral valve insufficiency – in elderly patients and patients with SLE lasting for 6–10 years; vein thro
介绍。系统性红斑狼疮(SLE)是一种具有多种临床表现和不可预测病程的疾病。它通常持续几个月或几年,交替缓解和恶化。多个器官可同时受到不同程度的严重影响,导致与治疗和疾病相关的合并症,包括循环系统疾病,这是SLE患者死亡的主要原因之一。研究的目的。了解系统性红斑狼疮患者循环系统脏器合并症病变的性质和频率,并根据性别、年龄和病程特征对其进行定性。材料和方法。在进行研究之前,所有患者根据《赫尔辛基人权宣言》、《欧洲委员会人权与生物医学公约》的要求签署了自愿同意。本研究纳入112例诊断为不同严重程度SLE患者,初步分层如下:女性89.29%,工作年龄患者(青年57.14%,中年39.29%),无业(58.04%),III残疾组患者(45.54%),城市居民(62.50%)。病程评估结果显示,大量SLE合并循环系统脏器合并症患者患病时间为1-5年(36.61%)和10年以上(38.39%)。所有患者都是2016年至2021年在利沃夫地区理事会公共非营利企业“利沃夫地区临床医院”风湿病科就诊的患者。研究分几个阶段进行,在此期间,循环系统共病病变的性质和频率与性别、年龄和疾病持续时间有关。结果。在研究完成时,几乎一半的SLE患者被诊断为雷诺综合征、二尖瓣功能不全和动脉粥样硬化,约1/3的SLE患者被诊断为心肌炎、视网膜血管病变、症状性动脉高血压和网状动脉炎。下肢静脉曲张、高血压疾病、弥漫性心脏硬化、三尖瓣不全、静脉血栓形成、血栓后静脉炎综合征、主动脉瓣不全、毛细血管炎、肺动脉高压、冠状动脉疾病(CAD)包括稳定型心绞痛、心肌病和梗死后心脏硬化的发生率呈下降趋势。雷诺综合征在女性和年轻人中更为常见;视网膜血管病变、网状增生和症状性动脉高血压-女性和SLE持续10年以上的患者;心肌炎、下肢静脉曲张——男性;毛细血管炎——发生在病程最短的SLE患者;动脉粥样硬化和二尖瓣功能不全-老年患者和持续6-10年的SLE患者;静脉血栓和稳定型心绞痛——在老年患者和持续10年以上的SLE患者中;高血压病、弥漫性心脏硬化、主动脉瓣功能不全、梗死后心脏硬化是老年SLE患者的最典型特征。结论。在系统性红斑狼疮患者中,发现许多循环系统器官合并症病变。通过对其性质和发生频率的研究,并根据性别、年龄和病程对其进行定性分析,得出系统性红斑狼疮患者循环系统疾病筛查检查应考虑的特点,并对其进行综合护理,以提高患者的生活质量。考虑到这一点,系统性红斑狼疮需要进一步的详细研究。
{"title":"Circulatory System Organs Comorbid Lesions in Patients with Systemic Lupus Erythematosus: Nature and Frequency; Characteristics Depending on Gender, Age and Disease Duration","authors":"L. Kobak, O. Abrahamovych, U. Abrahamovych, R. Ivanochko, V. Chemes","doi":"10.25040/lkv2022.03-04.066","DOIUrl":"https://doi.org/10.25040/lkv2022.03-04.066","url":null,"abstract":"Introduction. Systemic lupus erythematosus (SLE) is a disease with numerous clinical manifestations and an unpredictable course. It often lasts for several months or years, with alternating remissions and exacerbations. Multiple organs can be affected simultaneously with varying degrees of severity, resulting in treatment- and disease-related comorbidities, including circulatory system diseases, which are one of the leading causes of death of SLE patients. The aim of the study. To find out the nature and frequency of the circulatory system organs comorbid lesions in patients with systemic lupus erythematosus, to characterize them depending on the gender, age and the disease duration. Materials and methods. Prior to performing the study all patients signed the voluntary consent to participate in accordance with the requirements of Helsinki Declaration of Human Rights, the Council of Europe Convention on Human Rights and Biomedicine. The cohort under investigation included 112 patients with diagnosed SLE of different severity with preliminary stratification as follows: females 89.29 %, patients of working age (57.14 % – young and 39.29 % – middle aged), unemployed (58.04 %), III disability group patients (45.54 %), city residents (62.50 %). According to the results of the disease duration assessment, a significant number of patients with SLE and circulatory system organs comorbid lesions have been ill for 1–5 years (36.61 %) and more than 10 years (38.39 %). All of them were patients of the rheumatology department of the Communal Non-Profit Enterprise of the Lviv Regional Council “Lviv Regional Clinical Hospital” from 2016 to 2021.The research was carried out in several stages, during which the nature and frequency of the circulatory system comorbid lesions with respect to gender, age and disease duration were estimated. Results. While completing the study, almost half of patients with SLE were diagnosed with Raynaud’s syndrome, mitral valve insufficiency and atherosclerosis, about 1/3 – with myocarditis, retinal angiopathy, symptomatic arterial hypertension and livedo reticularis. The varicose veins of the lower extremities, hypertensive disease, diffuse cardiosclerosis, tricuspid valve insufficiency, vein thrombosis, post-thrombophlebitis syndrome, aortic valve insufficiency, capillaritis, pulmonary hypertension, coronary artery disease (CAD) including stable angina pectoris, cardiomyopathy and post-infarction cardiosclerosis were found with the decreasing frequency. Raynaud’s syndrome was significantly more often diagnosed in females and young people; retinal angiopathy, livedo reticularis and symptomatic arterial hypertension – in females and those patients whose SLE lasted for more than 10 years; myocarditis, varicose veins of the lower extremities – in males; capillaritis – in patients with the shortest duration of SLE; atherosclerosis and mitral valve insufficiency – in elderly patients and patients with SLE lasting for 6–10 years; vein thro","PeriodicalId":279640,"journal":{"name":"Lviv clinical bulletin","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130362218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Dynamics of Clinical Signs and Inflammatory Biomarker Neopterin Level in Blood Serum of Rabbits with Experimental Non-infectious Autoimmune Uveitis with Respect to Different Degrees of its Severity 实验性非感染性自身免疫性葡萄膜炎不同严重程度兔临床体征及血清炎症标志物新蝶呤水平的动态变化
Pub Date : 2023-01-02 DOI: 10.25040/lkv2022.03-04.033
N. Kuryltsiv, O. Zborovska, L. Velychko, A. Khyrivskyi
Introduction. Uveitis is an inflammatory condition involving iris, ciliary body and choroid of the eyebulb. Uveitis curretntly affects about two million people worldwide and is among five leading causes of blindness in the working population. Diagnosis of uveitis requires a number of investigations. As important biomarker in the diagnosis of uveitis can be used the detection of Neopterin (NP) in blood serum, since it is a stable metabolite and its increased level encompass activation of cellular immunity. It should be also noted that NP is present in blood serum and plasma, urine, tears, aqueous humor, vitreous body, other biological fluids and can be easily detected. According to literature data and our own investigations, the concentration of NP usually depends on the degree of activity of the pathological process, and its high concentration of NP is one of the main predictors of an unfavorable prognosis. The aim of the study. To investigate the dynamics of clinical signs and inflammatory biomarker Neopterin level in blood serum of rabbits with experimental non-infectious autoimmune uveitis (NAU) considering varying degrees of severity. Materials and methods. The experimental study was conducted on 30 rabbits of the “Chinchilla” breed, which were divided into two main groups (I and II), 15 animals in each. NAU was induced by intravitreal injection of an undiluted normal sterile horse serum to group I rabbits, while group II animals received diluted with the physiological solution serum in the proportion of 1:2. General sensitization was previously carried out with the same serum injected intravenously. Results. The average level of NP in rabbits before the start of the experiment was 1.7 ± 0.2 nmol/l. It was considered the norm, since there is no information in the literature about the study of NP in healthy rabbits of the “Chinchilla” breed. In the reported research the severity of experimental NAU was estimated due to the concentration of the injected normal sterile horse serum intravitreally. As an additional proof of the development of NAU clinical picture was used the detection of Neopterin concentration in blood serum of rabbits. In both group animals the development of acute inflammation on days 3, 7, 10 and 14 of experiment the NP level was significantly higher compared to control (p-value less than 0.05). However, in the I group animals with moderate and severe NAU, the level of NP was significantly higher than that in group II, in which uveitis was characterized by a mild course. Namely, on the 3rd day of experiment NP concentration in the I group animals was 5.60 ± 0.70 nmol/l, in the group II – 4.70 ± 0.60 nmol/l (p-value less than 0.05); on day 7th – 6.00 ± 0.20 nmol/l and 4.45 ± 0.30 nmol/l (p-value less than 0.05); on day 10th – 5.90 ± 0.40 nmol/l and 2.60 ± 0.40 nmol/l (p-value less than 0.05); on the 14th – 3.80 ± 0.40 nmol/l and 2.10 ± 0.10 nmol/l (p-value less than 0.05). On the day 21st, the NP concentration in both group an
介绍。葡萄膜炎是一种累及虹膜、睫状体和眼球脉络膜的炎症。葡萄膜炎目前影响着全世界约200万人,是导致劳动人口失明的五大主要原因之一。葡萄膜炎的诊断需要大量的检查。新蝶呤(NP)是一种稳定的代谢物,其水平升高可激活细胞免疫,可作为诊断葡萄膜炎的重要生物标志物。还应注意的是,NP存在于血清和血浆、尿液、泪液、房水、玻璃体和其他生物体液中,并且很容易检测到。根据文献资料和我们自己的研究,NP的浓度通常取决于病理过程的活动程度,其高浓度NP是不良预后的主要预测因素之一。研究的目的。探讨不同严重程度的实验性非感染性自身免疫性葡萄膜炎(NAU)兔的临床体征和血清炎症生物标志物Neopterin水平的动态变化。材料和方法。实验研究选用“Chinchilla”品种家兔30只,分为两组(I组和II组),每组15只。采用未稀释的正常无菌马血清玻璃体腔内注射诱导NAU, II组用生理溶液血清按1:2的比例稀释。一般致敏以前是通过静脉注射相同的血清进行的。结果。实验开始前家兔NP的平均水平为1.7±0.2 nmol/l。这被认为是一种规范,因为在文献中没有关于“栗鼠”品种的健康兔子NP研究的信息。在报道的研究中,通过玻璃体内注射正常无菌马血清的浓度来估计实验性NAU的严重程度。为了进一步证明NAU技术的发展,我们采用了兔血清中新蝶呤浓度的检测方法。两组动物在实验第3、7、10、14天出现急性炎症时,NP水平均显著高于对照组(p值均小于0.05)。然而,在中度和重度NAU的I组动物中,NP水平明显高于以轻度病程为特征的II组。即实验第3天,ⅰ组动物NP浓度为5.60±0.70 nmol/l,ⅱ组动物NP浓度为- 4.70±0.60 nmol/l (p值< 0.05);第7天- 6.00±0.20 nmol/l和4.45±0.30 nmol/l (p值< 0.05);第10天- 5.90±0.40 nmol/l和2.60±0.40 nmol/l (p值< 0.05);14日分别为3.80±0.40 nmol/l和2.10±0.10 nmol/l (p值< 0.05)。在第21天,两组动物的NP浓度无统计学差异-估计水平为2.70±0.30 nmol/l (p值大于0.05)-这显然包含了眼部炎症变化的消退。结论。研究了兔非感染性自身免疫性葡萄膜炎严重程度与血清炎症生物标志物新蝶呤浓度的相关性。实验第3天、第7天、第10天和第14天,所有实验动物的NP水平均升高,与NP对照组相比有统计学差异。在葡萄膜炎病程较重的动物组中,NP水平明显高于病程较轻的动物。这一观察结果证实了机体对炎症的免疫反应和血清中NP生物标志物的稳定性。两个实验组家兔体内该生物标志物水平的动态变化与临床变化的动态变化相关。血清中炎症生物标志物新蝶呤素的检测可作为评估非感染性自身免疫性葡萄膜炎严重程度、病程和预后的标准。
{"title":"Dynamics of Clinical Signs and Inflammatory Biomarker Neopterin Level in Blood Serum of Rabbits with Experimental Non-infectious Autoimmune Uveitis with Respect to Different Degrees of its Severity","authors":"N. Kuryltsiv, O. Zborovska, L. Velychko, A. Khyrivskyi","doi":"10.25040/lkv2022.03-04.033","DOIUrl":"https://doi.org/10.25040/lkv2022.03-04.033","url":null,"abstract":"Introduction. Uveitis is an inflammatory condition involving iris, ciliary body and choroid of the eyebulb. Uveitis curretntly affects about two million people worldwide and is among five leading causes of blindness in the working population. Diagnosis of uveitis requires a number of investigations. As important biomarker in the diagnosis of uveitis can be used the detection of Neopterin (NP) in blood serum, since it is a stable metabolite and its increased level encompass activation of cellular immunity. It should be also noted that NP is present in blood serum and plasma, urine, tears, aqueous humor, vitreous body, other biological fluids and can be easily detected. According to literature data and our own investigations, the concentration of NP usually depends on the degree of activity of the pathological process, and its high concentration of NP is one of the main predictors of an unfavorable prognosis. The aim of the study. To investigate the dynamics of clinical signs and inflammatory biomarker Neopterin level in blood serum of rabbits with experimental non-infectious autoimmune uveitis (NAU) considering varying degrees of severity. Materials and methods. The experimental study was conducted on 30 rabbits of the “Chinchilla” breed, which were divided into two main groups (I and II), 15 animals in each. NAU was induced by intravitreal injection of an undiluted normal sterile horse serum to group I rabbits, while group II animals received diluted with the physiological solution serum in the proportion of 1:2. General sensitization was previously carried out with the same serum injected intravenously. Results. The average level of NP in rabbits before the start of the experiment was 1.7 ± 0.2 nmol/l. It was considered the norm, since there is no information in the literature about the study of NP in healthy rabbits of the “Chinchilla” breed. In the reported research the severity of experimental NAU was estimated due to the concentration of the injected normal sterile horse serum intravitreally. As an additional proof of the development of NAU clinical picture was used the detection of Neopterin concentration in blood serum of rabbits. In both group animals the development of acute inflammation on days 3, 7, 10 and 14 of experiment the NP level was significantly higher compared to control (p-value less than 0.05). However, in the I group animals with moderate and severe NAU, the level of NP was significantly higher than that in group II, in which uveitis was characterized by a mild course. Namely, on the 3rd day of experiment NP concentration in the I group animals was 5.60 ± 0.70 nmol/l, in the group II – 4.70 ± 0.60 nmol/l (p-value less than 0.05); on day 7th – 6.00 ± 0.20 nmol/l and 4.45 ± 0.30 nmol/l (p-value less than 0.05); on day 10th – 5.90 ± 0.40 nmol/l and 2.60 ± 0.40 nmol/l (p-value less than 0.05); on the 14th – 3.80 ± 0.40 nmol/l and 2.10 ± 0.10 nmol/l (p-value less than 0.05). On the day 21st, the NP concentration in both group an","PeriodicalId":279640,"journal":{"name":"Lviv clinical bulletin","volume":"347 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124286750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prostaglandin E2 in the Blood Serum of Patients with Gastroduodenal Erosive-Ulcerative Lesions with and without Comorbid Hypertension 伴有和不伴有高血压的胃十二指肠糜烂性溃疡病变患者血清前列腺素E2的变化
Pub Date : 2023-01-02 DOI: 10.25040/lkv2022.03-04.021
Y. Sklyarov, A. Chetaykina, M. Mbarki, O. Kapustinsky
Introduction. The combination of erosive-ulcerative lesions (EUI) of the gastroduodenal zone with hypertension (HT) is a common phenomenon and is a modern medicine’s pressing issue. Taking nonsteroidal anti-inflammatory drugs (NSAIDs), including by patients with HT, is accompanied by prostaglandin synthesis suppression due to cyclooxygenase inhibition and results in an arterial pressure increase. Moreover, it should be mentioned that patients with HT have a higher risk of gastroduodenal lesions. The aim of the study. To explore the prostaglandin E2 content in the blood serum of patients with gastroduodenal erosive-ulcerative lesions without and with comorbid hypertension. Materials and methods. The research involved 20 patients with gastroduodenal EUI without comorbid HT and 30 patients with gastroduodenal EUI suffering comorbid HT. All patients went through general clinical examinations, esophagogastroduodenofibroscopy (EGDFS), and stool tests to verify H.pylori infection, with prostaglandin E2 (PGE2) content in blood serum being determined. Results. EGDFS showed that among patients with gastroduodenal EUI without comorbid HT, 25.00 % were diagnosed with gastric EUI; half of the cases (50.00 %) revealed duodenum lesions, and another 25.00 % – combined stomach and duodenum lesions. At the same time, patients with EUI combined with comorbid HT manifested more frequent (p-value less than 0.05) gastric localization of mucosal EUI (50.00 %); 16.67 % of patients had the duodenum lesions, while combined stomach and duodenum defects were observed in 33.33 %. H. pylori infection was confirmed in 13 patients (65.00 %) with EUI without comorbid HT and in 22 examined individuals (73.33 %) with the gastroduodenal zone EUI and comorbid HT. The endogenous PGE2 was significantly higher in patients who had only gastric mucosa and duodenum EUI without comorbid HT and amounted to 2135.79 ± 80.94 pg/ml (p-value less than 0.05), while patients with EUI and comorbid HT were tested a significantly lower PGE2 level in blood serum – 1513.55 ± 92.48 pg/ml. At the same time, the significantly lower PGE2 level in patients with EUI and comorbid HT compared to the similar indicator in patients without it explains the differences in the EUI distribution in both groups of patients revealed during endoscopic examination. Since a significantly weakened PGE2 synthesis leads to lower bicarbonate and mucus secretion and more intensive acid production, the balance between the aggression and protection factors is upset, which contributes to the EUI emergence mainly in the stomach’s antral part. The research has exposed no significant difference in PGE2 content in patients with duodenum mucosa EUI and those with a combination of gastric and duodenum mucosa lesions (p-value more than 0.05). Besides, the PGE2 content was tested significantly lower in patients with EUI gastric localization, than in those with combined ulcers (p-value less than 0.05). The presence or absence of H. pylori
介绍。胃十二指肠糜烂性溃疡病变(EUI)合并高血压(HT)是一种常见现象,也是现代医学亟待解决的问题。服用非甾体抗炎药(NSAIDs),包括HT患者,由于环加氧酶抑制,前列腺素合成受到抑制,导致动脉压升高。此外,需要指出的是,HT患者发生胃十二指肠病变的风险更高。研究的目的。探讨无及合并高血压的胃十二指肠糜烂性溃疡患者血清中前列腺素E2的含量。材料和方法。本研究纳入20例未合并HT的胃十二指肠EUI患者和30例合并HT的胃十二指肠EUI患者。所有患者均通过一般临床检查、食管胃十二指肠纤维镜检查(EGDFS)和粪便检查确认幽门螺杆菌感染,并测定血清前列腺素E2 (PGE2)含量。结果。EGDFS显示,在未合并HT的胃十二指肠EUI患者中,25.00%被诊断为胃EUI;一半的病例(50.00%)表现为十二指肠病变,另有25.00%为胃和十二指肠合并病变。同时,EUI合并HT患者胃粘膜EUI定位发生率更高(p值< 0.05)(50.00%);十二指肠病变占16.67%,胃、十二指肠合并缺损占33.33%。13例未合并HT的EUI患者(65.00%)确诊幽门螺杆菌感染,22例伴有胃十二指肠区EUI和合并HT的患者(73.33%)确诊幽门螺杆菌感染。内源性PGE2在仅胃粘膜和十二指肠EUI且无合并HT的患者中显著升高,为2135.79±80.94 pg/ml (p值< 0.05),而合并EUI和合并HT的患者血清中PGE2水平显著降低,为1513.55±92.48 pg/ml。同时,有EUI并合并HT的患者的PGE2水平明显低于无该指标的患者,这也解释了两组患者在内镜检查中发现的EUI分布的差异。由于PGE2合成明显减弱,导致碳酸氢盐和黏液分泌减少,酸分泌增加,破坏了攻击因子和保护因子之间的平衡,导致EUI主要发生在胃的胃窦部。本研究发现十二指肠粘膜EUI患者与胃十二指肠粘膜合并病变患者PGE2含量无显著差异(p值大于0.05)。此外,EUI胃定位患者的PGE2含量显著低于合并溃疡患者(p值小于0.05)。有无幽门螺杆菌感染也不影响内源性PGE2水平(p值大于0.05)。结论。胃十二指肠糜烂性溃疡伴高血压患者血清中前列腺素E2含量明显低于无高血压伴胃十二指肠糜烂性溃疡患者。此外,合并高血压的胃十二指肠糜烂性溃疡患者血清中前列腺素E2显著降低,破坏了攻击因子和保护因子之间的平衡,导致糜烂性溃疡缺陷的出现,主要发生在胃。
{"title":"Prostaglandin E2 in the Blood Serum of Patients with Gastroduodenal Erosive-Ulcerative Lesions with and without Comorbid Hypertension","authors":"Y. Sklyarov, A. Chetaykina, M. Mbarki, O. Kapustinsky","doi":"10.25040/lkv2022.03-04.021","DOIUrl":"https://doi.org/10.25040/lkv2022.03-04.021","url":null,"abstract":"Introduction. The combination of erosive-ulcerative lesions (EUI) of the gastroduodenal zone with hypertension (HT) is a common phenomenon and is a modern medicine’s pressing issue. Taking nonsteroidal anti-inflammatory drugs (NSAIDs), including by patients with HT, is accompanied by prostaglandin synthesis suppression due to cyclooxygenase inhibition and results in an arterial pressure increase. Moreover, it should be mentioned that patients with HT have a higher risk of gastroduodenal lesions. The aim of the study. To explore the prostaglandin E2 content in the blood serum of patients with gastroduodenal erosive-ulcerative lesions without and with comorbid hypertension. Materials and methods. The research involved 20 patients with gastroduodenal EUI without comorbid HT and 30 patients with gastroduodenal EUI suffering comorbid HT. All patients went through general clinical examinations, esophagogastroduodenofibroscopy (EGDFS), and stool tests to verify H.pylori infection, with prostaglandin E2 (PGE2) content in blood serum being determined. Results. EGDFS showed that among patients with gastroduodenal EUI without comorbid HT, 25.00 % were diagnosed with gastric EUI; half of the cases (50.00 %) revealed duodenum lesions, and another 25.00 % – combined stomach and duodenum lesions. At the same time, patients with EUI combined with comorbid HT manifested more frequent (p-value less than 0.05) gastric localization of mucosal EUI (50.00 %); 16.67 % of patients had the duodenum lesions, while combined stomach and duodenum defects were observed in 33.33 %. H. pylori infection was confirmed in 13 patients (65.00 %) with EUI without comorbid HT and in 22 examined individuals (73.33 %) with the gastroduodenal zone EUI and comorbid HT. The endogenous PGE2 was significantly higher in patients who had only gastric mucosa and duodenum EUI without comorbid HT and amounted to 2135.79 ± 80.94 pg/ml (p-value less than 0.05), while patients with EUI and comorbid HT were tested a significantly lower PGE2 level in blood serum – 1513.55 ± 92.48 pg/ml. At the same time, the significantly lower PGE2 level in patients with EUI and comorbid HT compared to the similar indicator in patients without it explains the differences in the EUI distribution in both groups of patients revealed during endoscopic examination. Since a significantly weakened PGE2 synthesis leads to lower bicarbonate and mucus secretion and more intensive acid production, the balance between the aggression and protection factors is upset, which contributes to the EUI emergence mainly in the stomach’s antral part. The research has exposed no significant difference in PGE2 content in patients with duodenum mucosa EUI and those with a combination of gastric and duodenum mucosa lesions (p-value more than 0.05). Besides, the PGE2 content was tested significantly lower in patients with EUI gastric localization, than in those with combined ulcers (p-value less than 0.05). The presence or absence of H. pylori ","PeriodicalId":279640,"journal":{"name":"Lviv clinical bulletin","volume":"9 9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134584957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Lviv clinical bulletin
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1